{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:33:42Z","timestamp":1770564822808,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1038\/nm0298-232","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:57:03Z","timestamp":1092880623000},"page":"232-234","source":"Crossref","is-referenced-by-count":370,"title":["bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice"],"prefix":"10.1038","volume":"4","author":[{"given":"Burkhard","family":"Jansen","sequence":"first","affiliation":[]},{"given":"Hermine","family":"Schlagbauer-Wadl","sequence":"additional","affiliation":[]},{"given":"Bob D.","family":"Brown","sequence":"additional","affiliation":[]},{"given":"Robert N.","family":"Bryan","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Van Elsas","sequence":"additional","affiliation":[]},{"given":"Markus","family":"M\u00fcller","sequence":"additional","affiliation":[]},{"given":"Klaus","family":"Wolff","sequence":"additional","affiliation":[]},{"given":"Hans-Georg","family":"Eichler","sequence":"additional","affiliation":[]},{"given":"Hubert","family":"Pehamberger","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm0298232_CR1","first-page":"7","volume":"44","author":"CC Boring","year":"1994","unstructured":"Boring, C.C., Squires, T.S., Tong, T. & Montgomery, S. Cancer statistics 1994. CA: Cancer J. Clinic 44, 7\u201326 (1994).","journal-title":"CA: Cancer J. Clinic"},{"key":"BFnm0298232_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0959-8049(96)00080-9","volume":"32A","author":"JA Hickman","year":"1996","unstructured":"Hickman, J.A. Apoptosis and chemotherapy resistance. Eur. J. Cancer 32A, 921\u2013926 (1996).","journal-title":"Eur. J. Cancer"},{"key":"BFnm0298232_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00000372-199502000-00002","volume":"17","author":"L Cerroni","year":"1995","unstructured":"Cerroni, L., Soyer, H.P. & Kerl, H. bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi. Am. J. Dermatopathol. 17, 7\u201311 (1995).","journal-title":"Am. J. Dermatopathol."},{"key":"BFnm0298232_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/archderm.1995.01690200045009","volume":"131","author":"CRJ Morales-Ducret","year":"1995","unstructured":"Morales-Ducret, C.R.J., van deRijn, M., LeBrun, D.P. & Smoller, B.R. bcl-2 expression in primary malignancies of the skin. Arch. Dermatol. 131, 909\u2013918 (1995).","journal-title":"Arch. Dermatol."},{"key":"BFnm0298232_CR5","first-page":"651","volume":"146","author":"A Plettenberg","year":"1995","unstructured":"Plettenberg, A. et al. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture. Am. J. Pathol. 146, 651\u2013659 (1995).","journal-title":"Am. J. Pathol."},{"key":"BFnm0298232_CR6","first-page":"643","volume":"146","author":"VA Tron","year":"1995","unstructured":"Tron, V.A. et al. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am. J. Pathol. 146, 643\u2013650 (1995).","journal-title":"Am. J. Pathol."},{"key":"BFnm0298232_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0748-7983(96)90176-6","volume":"22","author":"R Grover","year":"1996","unstructured":"Grover, R. & Wilson, C.D. Bcl-2 expression in malignant melanoma and its prognostic significance. Eur. J. Surg. Oncol. 22, 347\u2013349 (1996).","journal-title":"Eur. J. Surg. Oncol."},{"key":"BFnm0298232_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.8351515","volume":"261","author":"CA Stein","year":"1993","unstructured":"Stein, C.A. & Cheng, Y.-C. Antisense oligonucleotides as therapeutic agents\u2013Is the bullet really magical? Science 261, 1004\u20131012 (1993).","journal-title":"Science"},{"key":"BFnm0298232_CR9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nm1195-1119","volume":"1","author":"CA Stein","year":"1995","unstructured":"Stein, C.A. Does antisense exist? Nature Med. 1, 1119\u20131121 (1995).","journal-title":"Nature Med."},{"key":"BFnm0298232_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nbt0697-483","volume":"15","author":"RE Christoffersen","year":"1997","unstructured":"Christoffersen, R.E. Translating genomics information into therapeutics: A key role for oligonucleotides. Nature Biotechnol. 15, 483\u2013484 (1997).","journal-title":"Nature Biotechnol."},{"key":"BFnm0298232_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nm0696-668","volume":"2","author":"BP Monia","year":"1996","unstructured":"Monia, B.P., Johnston, J.F., Geiger, T., Muller, M. & Fabbro, D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nature Med. 2, 668\u2013675 (1996).","journal-title":"Nature Med."},{"key":"BFnm0298232_CR12","first-page":"165","volume":"60","author":"RL Comis","year":"1976","unstructured":"Comis, R.L. DTIC (NSC-45388) in malignant melanoma: A perspective. Cancer Treat Rep. 60, 165\u2013176 (1976).","journal-title":"Cancer Treat Rep."},{"key":"BFnm0298232_CR13","first-page":"395","volume":"12","author":"SP Henry","year":"1997","unstructured":"Henry, S.P., Monteith, D. & Levin, A.A. Antisense oligonucleotide inhibitors for the treatment of cancer. 2. Toxicological properties of phosphorothioate oligonucleotides. Anti-Cancer Drug Des. 12, 395\u2013408 (1997).","journal-title":"Anti-Cancer Drug Des."},{"key":"BFnm0298232_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/374546a0","volume":"374","author":"AM Krieg","year":"1995","unstructured":"Krieg, A.M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546\u2013549 (1995).","journal-title":"Nature"},{"key":"BFnm0298232_CR15","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood.V89.8.2994","volume":"89","author":"JE Wooldridge","year":"1997","unstructured":"Wooldridge, J.E., Ballas, Z., Krieg, A.M. & Weiner, G.J. Immunostimulatory oligonucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood, 89, 2994\u20132998 (1997).","journal-title":"Blood"},{"key":"BFnm0298232_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(96)11103-X","volume":"349","author":"A Webb","year":"1997","unstructured":"Webb, A. et al. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 349, 1137\u20131141 (1997).","journal-title":"Lancet"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0298-232","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0298-232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0298-232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:02:13Z","timestamp":1684447333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0298-232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["BFnm0298232"],"URL":"https:\/\/doi.org\/10.1038\/nm0298-232","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}